Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

BACKGROUND: FOLFIRINOX is a standard treatment for metastatic pancreatic cancer patients. The effectiveness of neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer (BRPC) remains debated. METHODS: We performed a systematic review and patient-level meta-analysis on neoadjuv...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Natl Cancer Inst
Auteurs principaux: Janssen, Quisette P, Buettner, Stefan, Suker, Mustafa, Beumer, Berend R, Addeo, Pietro, Bachellier, Philippe, Bahary, Nathan, Bekaii-Saab, Tanios, Bali, Maria A, Besselink, Marc G, Boone, Brian A, Chau, Ian, Clarke, Stephen, Dillhoff, Mary, El-Rayes, Bassel F, Frakes, Jessica M, Grose, Derek, Hosein, Peter J, Jamieson, Nigel B, Javed, Ammar A, Khan, Khurum, Kim, Kyu-Pyo, Kim, Song Cheol, Kim, Sunhee S, Ko, Andrew H, Lacy, Jill, Margonis, Georgios A, McCarter, Martin D, McKay, Colin J, Mellon, Eric A, Moorcraft, Sing Yu, Okada, Ken-Ichi, Paniccia, Alessandro, Parikh, Parag J, Peters, Niek A, Rabl, Hans, Samra, Jaswinder, Tinchon, Christoph, van Tienhoven, Geertjan, van Veldhuisen, Eran, Wang-Gillam, Andrea, Weiss, Matthew J, Wilmink, Johanna W, Yamaue, Hiroki, Homs, Marjolein Y V, van Eijck, Casper H J, Katz, Matthew H G, Groot Koerkamp, Bas
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Reviews
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6695305/
https://ncbi.nlm.nih.gov/pubmed/31086963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djz073
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires